Results of endovascular correction of atrial septal defect and early heart remodeling in children of preschool and school age

Aim. To analyze the results and features of early cardiac remodeling (CR) in children of preschool and school age after endovascular correction of atrial septal defect (ASD).

Material and methods. A prospective study included 27 children with secondary ASD who underwent endovascular correction for one year (from the beginning of 2017 to the beginning of 2018). The patients were divided into two groups. The first (n=12) — children of preschool age (<8 years old), mean age 4,5 [3;6], and the second (n=15) — school age (8­18 years old), mean age 12 [9;14]. The following indicants were assessed during hospitalization: the success of the intervention, hospital complications, functional data characterizing CR according to echocardiography before and after the correction of the defect.

Results. It was shown that all children successfully completed endovascular closure of ASD. Complications were not identified. We find several statistically significant changes in echocardiogram data before and after the intervention. In the preschool age group, the size of the right ventricle (RV) decreased from 1,66 to 1,45 cm (p=0,028), the right atrium (RA) decreased from 3,58 to 3,1 cm (p=0,003), and the longitudinal size of RV decreased from 3 to 2 cm (p=0,032) and basal size of RV — from 5,98 to 4,4 cm (p=0,005), the volume of RA decreased from 25,7 to 20,7 ml (p=0,005). In the group of school age, the size of the RV changed from 2,08 to 1,8 cm (p=0,038), the size of the RA — from 3,72 to 2,71 cm (p=0,007), the RV area in diastole — from 12,4 to 10,6 mm2. The gradient has changed from 2 to 1,54 mm Hg (p=0,043), the frontal size of the tricuspid valve (TV) decreased from 2,7 to 2,48 cm (p=0,010). The basal size of RV decreased from 3 to 2,6 cm (p=0,015), the median
size — from 2,73 to 2,37 cm (p=0,017) and the longitudinal size — from 5,97 to 5,45 cm (p=0,007). No significant differences in CR among the groups were found.

Conclusion. We made conclusion about the efficacy and safety of endovascular correction of ASD, which has a positive effect on early HR in children, both in early and in old age.

1. Shabaldin AV, Glebova LA, Bachina AV, et al. Features of epidemiology of congenital heart diseases at children Kemerovo. Complex Issues of Cardiovascular Diseases. 2014;(4):38-46. (In Russ.) https://doi.org/10.17802/2306-1278-2014-4-38-46

2. Nechkina IV, Sokolov АА, Kovalev IA, et al. Heart remodeling in children after endovascular and surgical repair of atrial septal defect. Siberian J. Medical. 2012; 27(3): 77-81. (In Russ.)

3. De Meester P, Van De Bruaene A, Herijgers P, et al. Increased pulmonary artery pressures during exercise are related to persistent tricuspid regurgitation after septal defect closure. Acta Cardiol. 2013; 68(4): 365–72. doi:10.1016/j.amjcard.2009.05.017

4. Kim NK, Park Su-Jin, Choi JYo. Transcatheter Closure of Atrial Septal Defect: Does Age Matter? Korean Circ J. 2011 Nov; 41(11): 633–638.

5. Badran HM, Soltan GM, Alrefaey Atwa MA. Atrial septal defects: clinical presentation and recent approach in its diagnosis and treatment. Menoufia Med J 2014;27:145-51

6. Bockeria LA. Clinical recommendations for management of children with congenital heart disease. RACVS 14. https://racvs.ru/custom/files/clinic/Nac_rec_VPS_deti.pdf (2014) (In Russ.)

7. Siwińska A, Mroziński V, Górzna-Kamiska H, et al. Echocardiographic parameters of left ventricular systolic and diastolic function in infants, children and adolescents before and after surgical correction of secundum atrial septal defect. Kardiol. Pol. 2002; 57(11): 422–34. PMID: 12961003

8. Kuzmina OK, Rutkovskaya NV. Myocardial remodeling in patients with valvular heart disease. Siberian medical review. 2014; 2(104): 5-14. (in Russ).

9. Tuleutaev RM, Bogachev-Prokofiev AV, Zheleznev SI. Reverse remodeling of the left chambers of the heart after reconstruction of the mitral valve with mesenchymal dysplasia. Pathology of blood circulation and cardiosurgery. 2015; 19(1): 66-71 (in Russ).

10. Butera G, Saracino A, Danna P, et al. Transcatheter PFO closure with GORE septal occluder: early and mid-term clinical results. Catheter Cardiovasc Interv 2013;82:944–9. doi:10.1002/ccd.25106.

11. Qiu X, Lü B, Xu N, et al. Feasibility of device closure for multiple atrial septal defects using 3D printing and ultrasound-guided intervention technique. Zhonghua Yi Xue Za Zhi. 2017 Apr 25;97(16):1214-1217. doi:10.3760/cma.j.issn.0376-2491.2017.16.006.

12. Knop MT, Białkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under 3 years of age. Kardiol Pol. 2018 Jun 4. doi:10.5603/KP.a2018.0113.

13. Turner DR, Owada CY, Sang CJ Jr, et al. Closure of Secundum atrial septal defects with the AMPLATZER septal occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv. 2017 Aug;10(8). pii: e004212. doi:10.1161/CIRCINTERVENTIONS.116.004212.

14. Ooi YK, Kelleman M, Ehrlich A, et al. Transcatheter Versus Surgical Closure of Atrial Septal Defects in Children: A Value Comparison. JACC Cardiovasc Interv. 2016 Jan 11;9(1):79-86. doi:10.1016/j.jcin.2015.09.028.

15. Thomson JD, Aburawi EH, Watterson KG, et al. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 2002;87:466–9. PMCID: PMC1767102

16. Bissessor N. Current perspectives in percutaneous atrial septal defect closure devices. Med Devices (Auckl). 2015 Jul 15;8:297-303. doi:10.2147/MDER.S49368.